• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    India’s New Medical Devices Rules

    Discovering Packaging’s Hidden Value

    Deliberate Disposal: Single-Use & Disposables Technologies

    Illuminating Tubing’s Future

    Positive Identification: An Examination of Converting, Labeling, and Printing
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Remote Control Fires Laser at Nano-Gold to Activate Cancer-Killing Immune Cells

    FDA Clears Varian's Calypso Anchored Beacon Transponder for Lung

    Clinical Trial Tests 'Tattoo Sensor' as Needleless Glucose Monitor

    Chip-Based Multiple Myeloma Blood Test Could Eliminate Need for Bone Biopsies

    Pear Therapeutics and Novartis Ink Deal to Commercialize Prescription Digital Therapeutics
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    India’s New Medical Devices Rules

    Discovering Packaging’s Hidden Value

    Deliberate Disposal: Single-Use & Disposables Technologies

    Illuminating Tubing’s Future

    Positive Identification: An Examination of Converting, Labeling, and Printing
    Top 30 Medical Device Companies
    Top Top 30
    Top 30 Global Medical Device Companies

    1. Medtronic plc

    2. Johnson & Johnson

    3. GE Healthcare

    4. Siemens Healthineers
    Market Data
    Datawatch Column
    Salary Survey
    White Papers
    Top Research
    Extolling the Virtues of Surgical Simulation

    Will Medtech M&A Mania Continue?

    Learn from My Mistakes: Why You Need a Quality System

    Brexit: D-Day or the Y2K for Global Supply Chains?

    Planning for Brexit
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    GeoTec

    MTD Micro Molding

    Parker Precision Fluidics Division

    Currier Plastics Inc.

    Teel Plastics
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    Slideshows
    Top Resources
    Single-Use Device Reprocessing Tailwinds and Headwinds

    Healthcare Artificial Intelligence Market to Register Commendable 40 Percent CAGR Over 2017-2024

    Finding Talent in Healthcare IoT

    Transforming from Supplier to Partner

    Building a Better Package
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Salary Survey
      • Market Data
      • Datawatch Column
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    The Consumerization of Healthcare

    Related CONTENT
    • Theranos Enhances Executive Ranks
    • Johnson & Johnson Innovation, New York State, and New York Genome Center Launch JLABS in NYC
    • Edwards Lifesciences Completes Acquisition of Valtech Cardio
    • Verb Surgical Demonstrates First Digital Surgery Prototype
    • NeoChord Names Board Chairman
    Steve Maylish and Nick Rakhshani, Chief Commercial Officer, Fusion Biotec; Chief Marketing Officer, Satoba Technology Marketing01.30.17
    In the past (and, to a large degree, today), medical device companies focused on selling products to healthcare providers and payers. However, as healthcare moves away from a reactionary, fee-based care model to health and wellness or value-based models, more focus is now on the consumer/patient. Payers are realizing that reimbursement for fees, tests, and visits add cost to an already overburdened system. Over time, prevention is less expensive than treating an acute or chronic condition. This has led payers to reimburse for better patient care and deny payment or penalize for hospital-acquired conditions. In addition, many medical device users today consider themselves consumers, not patients.

    In 2017, the emphasis will continue to shift from provider-focused to patient-focused healthcare. No matter what happens to the Affordable Care Act, the current trend is toward consumer choice (health insurance competition), consumer empowerment (health savings accounts), and consumer wellness. Today more than ever, digital healthcare, the Internet of Things, value-based care, and healthcare reform are converging to drive the consumerization of healthcare.

    What improves patient outcomes and adds value? Does a smartphone application really change consumer habits? Can hospital readmission rates be impacted or infection rates reduced? As the cost burden shifts, consumers are enjoying more focus while healthcare providers and devices are subject to more scrutiny. As this trend continues, medical device designers will need to shift their focus as well.

    Unfortunately, patient outcome data is costly to generate and can sometimes require years of clinical work after a product launches. Determining product value and likelihood of improved outcomes early can be invaluable. Incorporating this knowledge into the innovation phase can ensure product acceptance. But today, most companies try to accomplish this by learning more about the customer, rather than the “job” that needs to be done.

    Clayton Christensen, best-selling author of “The Innovator’s Dilemma,” just released a new book titled, “Competing Against Luck” as a resource to help improve product design. To innovate, Christensen teaches that one must first discover what job consumers are hiring a product to do. This is then translated into a job specification: “What do I need in my new product, so that it does the consumer’s job well?” And finally, a company’s capabilities must be integrated in order to “nail the job consistently.” For medical products, the job of improving patient outcomes translates as the immediate result from a product or service and long-term benefit. In short, how well does the device do the intended job?

    As consumers take more control of their health, existing models are bound to change. For all Theranos and Elizabeth Holmes did wrong, they did have their business model right. What they didn’t have was technology to back up their claims. Theranos states on its website, “We are developing technologies that will enable us to make it possible for more people, in more places, to get the laboratory tests they need.” This shift to a consumer-centric model (i.e., small blood draw, convenient access at a local retail clinic, transparent online pricing, and no doctor visit) is at the heart of the company’s business model—and it is not alone in this pursuit. More companies are realizing that healthcare is shifting toward consumers, a classic case of “disruptive innovation.” As proof, in 2016, digital healthcare investment reached an all-time high of more than $6.5 billion.

    So how does a medical company create consumer-centric, disruptive innovation?

    It’s exciting to improve one’s quality of life, but as Theranos knows, there are risks involved in product innovation and disrupting existing models. Medical device development is a highly technical and costly undertaking. Marketing and development teams understand how data and analytics can drive decision-making. One of the unfortunate ideas resulting from data and customer analytics, however, is that to develop new products, we need to learn more “about” the customer.

    This need for customer or user data is more acute in medical design, where the product is submitted for approval to the U.S. Food and Drug Administration (FDA). In the submission, the FDA requires usability engineering reports. Usability engineering requires a focus on user profiles, use environment, and user interface. The idea is to identify use-related hazards, mitigate them, and validate safety and effectiveness. This human factors validation testing analyzes how the user interacts with the newly designed product and looks to reduce user-related errors.

    More customer data tells designers more about the customer, but very little about the actual job customers want done. It turns out that one of the best strategies for creating new products is a process called “jobs to be done.” This method of creating new and disruptive products was developed by Christensen, a professor at the Harvard Business School (HBS). Christensen observes that there are four reasons why customer information is a misguided path to innovation:
    1. Customer data shows only correlations and patterns.
    2. Customer data doesn’t reflect the experience of the customer and the job to be done.
    3. Companies have become comfortable in using data to make innovation decisions.
    4. Most data in market research is of the “correct” kind instead of the “true” kind.
    Christensen attributes the cause of failure in innovation to excessive emphasis on data and wanting to know more and more about customers. Instead, the emphasis should be on the “job to be done.” As HBS’s Ted Levitt pointed out decades ago, “people don’t want to buy a quarter-inch drill; they want something that will make a quarter-inch hole.” To be a successful innovator, you need to be good at figuring out what job consumers are hiring your product to do. Some tips to keep in mind:
    • The job is more than a task; it is an experience.
    • Circumstances are more important than data and product features.
    • Innovators solve problems that have less than satisfactory solutions.
    • Jobs are more than just functions. They also include emotional and relational dimensions.
    Traditional market segmentations (user profiles, for example) are based on correlation data and patterns with attributes such as age, gender, income level, and education level. Jobs-based segmentation looks to understand the root cause of purchase when a buyer needs to hire a product or service to get a job done. That job is not just about function, but also about creating the right set of experiences for customers. The four dimensions of “jobs to be done” include:
    1. Get a deep understanding of the job itself.
    2. Create the right experience for the purchase and use of the product.
    3. Develop a process across your business to support the job-to-be-done strategy.
    4. Observe tasks and jobs people would rather avoid.
    Observing tasks most people would rather not perform is easiest to miss; we tend to ignore tasks and jobs people would rather avoid. The avoidable tasks can become fertile ground for innovation. Some of the greatest innovators succeeded with little data and a lot of intuition. Equal knowledge can be gained from people who aren’t buying as from those who are. Customers performing workarounds often achieve less than satisfactory performance results—that need can be the seed for a new idea or concept.

    A recent study by Michael Devonas (affiliated with the Clayton Christensen Institute) titled, “For hire: Your neighborhood retail clinic,” is a great example of the “job to be done” concept in the new consumer-centric healthcare industry. It determined why a patient decided to visit a local retail pharmacy instead of the hospital emergency room (ER). The retail clinic, the study concluded, will become part of the eventual consumer-centric healthcare shift, and this transition will entail understanding the “job to be done.”

    The research interview of the patient revealed the following:
    • The patient was experiencing sharp pain in her stomach. It was not the first time she had experienced this particular symptom—it had happened three or four times before. The pain had subsided quickly in the past, but this time persisted and stayed constant throughout the day. Eventually, someone told her she looked sick.
    • Instead of dealing with the problem, she avoided it and hoped it would abate—it had gone away in the past. When it didn’t subside, and her ability to function socially was compromised, she called to check the neighborhood retail clinic’s availability. She made a conscious decision to avoid the ER because a good friend had recently ended up “trapped” in the waiting room for a week. This made her unwilling to experience the same frustration unless absolutely necessary.
    • The patient decided although she had never been to a retail clinic, it could help her decide whether or not to visit the ER. The patient was not worried about the cost of either, because she had good insurance. Her main reason for avoiding the ER was anxiety based on experiences of people close to her.
    • She found that the retail clinic wasn’t dramatic, and was also less stressful. Its low cost was not a factor, but the ability to triage her problem without frustration was. Other interviews conducted with patients who opted to visit retail clinics instead of the ER showed common patterns. One of these was avoidance of stressful situations, like talking to seemingly extraneous people about a condition. The retail clinic, on the other hand, provided simple sign in via computer.

    According to Devonas, the “job to be done” in this case was “Make the decision for me about whether to take a more aggressive treatment strategy for my condition, but don’t make an unnecessarily big deal of it.”

    The “job to be done” approach is instrumental in framing decision-making and providing solutions about human behavior. In this framework, consumers have a specific “job” that needs to be accomplished. They make a choice among tools “hired” to solve their problem. As Abraham Maslow once famously said, “If the only tool you have is a hammer, you tend to see every problem as a nail.” Therefore, the “job to be done” concept can help uncover the misunderstood causes of why consumers make decisions. In this situation, the patient was looking for a less stressful way to decide on a trip to the ER. Traditional marketing at a diagnostic instrument company may have concluded this was a decision to utilize a cheaper, easier manner of diagnosis.

    Because “job to be done” theory concentrates on a deeper understanding of the job and not the customer, it provides more useful information about the task and the experience. A product or service that takes consumers’ habits and anxieties into account can disrupt existing norms. Focusing only on customer profiles can obscure why a consumer makes a choice to “hire” a product to complete a job. The “job to be done” theory can, in turn, help engineers and marketers design products that provide more value and better patient outcomes. 


    Steve Maylish has been part of the medical device community for more than 30 years. He is currently chief commercial officer for Fusion Biotec, an Irvine, Calif.-based contract engineering firm that brings together art, science, and engineering to create medical devices. Early in his career, Maylish held positions at Fortune 100 corporations such as Johnson & Johnson, Shiley, Sorin Group, Baxter Healthcare, and Edwards Lifesciences.

    Nick Rakhshani is a marketer with a passion to help entrepreneurs, startups, and businesses multiply sales. He authored “Hyper Engaging Sales Funnels” a four-step framework for multiplying sales at scale. Rakhshani has more than 25 years of experience working with companies across a broad spectrum of industries. 
    Related Searches
    • human factors
    • development
    • interview
    • edwards lifesciences
    Related Knowledge Center
    • R&D & Design
    • Testing
    Suggested For You
    The Human Factor The Human Factor
    BD Appoints New President BD Appoints New President
    Theranos to Exit Lab Business for Two Years in Deal with CMS Theranos to Exit Lab Business for Two Years in Deal with CMS
    Defibtech Selects New CEO Defibtech Selects New CEO
    Terumo Cardiovascular Welcomes President and CEO Terumo Cardiovascular Welcomes President and CEO
    Why Manage, If You Can Lead? Why Manage, If You Can Lead?
    SPR Therapeutics Appoints New Member to Board of Directors SPR Therapeutics Appoints New Member to Board of Directors
    Edwards Found to Infringe on Boston Scientific Patents in Germany and U.K. Edwards Found to Infringe on Boston Scientific Patents in Germany and U.K.
    First in Man First in Man
    Trump’s 100-Day (Plus) Plan for Medtech M&A Trump’s 100-Day (Plus) Plan for Medtech M&A
    NeoChord Names Board Chairman NeoChord Names Board Chairman
    Verb Surgical Demonstrates First Digital Surgery Prototype Verb Surgical Demonstrates First Digital Surgery Prototype
    Edwards Lifesciences Completes Acquisition of Valtech Cardio Edwards Lifesciences Completes Acquisition of Valtech Cardio
    Johnson & Johnson Innovation, New York State, and New York Genome Center Launch JLABS in NYC Johnson & Johnson Innovation, New York State, and New York Genome Center Launch JLABS in NYC
    Theranos Enhances Executive Ranks Theranos Enhances Executive Ranks

    Related Columns

    • R&D & Design
      Shop Smart: How to Make the Most of the Prototype Phase

      Shop Smart: How to Make the Most of the Prototype Phase

      There are two basic types of people: Those who make sweeping generalizations, and those who don’t. (Actually, there’s a third type—one who opens columns with corny jokes and strains to hear the laugh track over the lonely cricket in…
      Dawn A. Lissy, President & Founder, Empirical 01.30.18

    • 3D/Additive Manufacturing | Testing
      The Final Four: My Top Headlines for 2017

      The Final Four: My Top Headlines for 2017

      In a year of political and social discord, international conflict, and natural disasters, the big news in the medical device industry really didn’t make headlines—even within our sector. But as 2017 comes to a close, I consider fee hikes,…
      Dawn A. Lissy, President & Founder, Empirical 11.07.17

    • R&D & Design
      Five Steps to Successfully Fail Early, Fast, and Often

      Five Steps to Successfully Fail Early, Fast, and Often

      The most successful innovators throughout history used a process called ideation in order to create products that make our lives better and more enjoyable. Thoughtful ideation shortens the development cycle, improves performance, and reduces cost. It…
      Steve Maylish and Mike White, Fusion Biotec 11.07.17


    • Packaging & Sterilization | Testing
      Packaging Validations—Looking Beyond ISO 11607

      Packaging Validations—Looking Beyond ISO 11607

      Most discussions on packaging validations for medical devices begin and end with ISO 11607: Packaging for Terminally Sterilized Medical Devices, and are laden with interpretations of how the two parts of this standard apply best to the unique aspects…
      Christopher Scott, Vice President, Eurofins Medical Device Testing 10.05.17

    • Diagnostics | R&D & Design
      Designing Diagnostic Consumables: Custom or Off-the-Shelf?

      Designing Diagnostic Consumables: Custom or Off-the-Shelf?

      Designing point-of-care diagnostic cartridges has always been a custom affair. Specialized designers and engineers use know-how in assay development, microfluidics, and systems engineering to develop a product from top to bottom. The result is a cust…
      Steve Maylish, Fusion Biotec, and Richard Spero, Redbud Labs 10.05.17

    • R&D & Design
      Charting a Course in Medical Innovation

      Charting a Course in Medical Innovation

      Something obviously was lost in translation. For more than 60 years, the West has found inspiration in the Chinese symbol for crisis. Conventional wisdom avows that the word’s Mandarin translation consists of two characters—one symboli…
      Michael Barbella, Managing Editor 09.01.17


    • R&D & Design
      Medtech Price Strategies: Who Is Going to Pay for It?

      Medtech Price Strategies: Who Is Going to Pay for It?

      Medical device product innovation and pricing strategy must be closely linked. In medtech product development, the three most important questions are: Is there an unmet need that can be answered with a medical device and what is it? I…
      Maria Shepherd, Medi-Vantage 09.01.17

    • Testing
      So We’re All on the Same Page: You Need a Test Plan

      So We’re All on the Same Page: You Need a Test Plan

      I’m a huge fan of lists. Covering every base with an organized way to track everything from my companies’ financial progress to whether the Doritos made it into the car for the drive home from school keeps me functioning. I note things on…
      Dawn A. Lissy, Empirical 09.01.17

    • R&D & Design
      The Value Creation Roadmap for Medical Technology Innovation

      The Value Creation Roadmap for Medical Technology Innovation

      Translating clinical research and medical technology innovation into a sustainable company is a complex and far-reaching process. First-time entrepreneurs, clinicians, and engineers often don’t appreciate the importance of the many factors invo…
      Steve Maylish, Fusion Biotec, and Scott Hutchinson, StoneCreek Capital 09.01.17


    • 3D/Additive Manufacturing | R&D & Design | Testing
      Pro Tips for Prototypes: The Smart Way to Manage Device Iterations

      Pro Tips for Prototypes: The Smart Way to Manage Device Iterations

      There’s something about hitting the prototype stage of the development cycle that makes everything finally seem real. This is the point at which there is finally an object to hold in your hands—a physical representation of the vision, inv…
      Dawn A. Lissy, Empirical 07.26.17

    • Digital Health | Software & IT | Testing
      Recent Cyber Attack Enough to Make Medtech WannaCry

      Recent Cyber Attack Enough to Make Medtech WannaCry

      It was the U.S. Food and Drug Administration’s (FDA) worst nightmare come true. On May 12, the WannaCry ransomware cryptoworm slithered its way into computers worldwide, infecting as many as 200,000 Microsoft Windows systems in 150 countries…
      Michael Barbella, Managing Editor 06.06.17

    • R&D & Design
      The Buck Starts Here

      The Buck Starts Here

      Commercialization is the confluence of all prior activities, a time of high investment and high anxiety. Here the rubber meets the road—yet for a new device, visibility on that road is often quite poor. A regulatory agency approved your device…
      Steve Maylish, Chief Commercial Officer, Fusion Biotec, and Ben Bobo, CEO, NeuroTemp LLC 06.06.17

    • R&D & Design | Testing
      The Human Factor

      The Human Factor

      Humans come in all shapes and sizes, ages, and abilities. Sometimes they aren’t logical. Engineers come with logical, rational minds, but sometimes don’t consider emotional behavior. Factoring humans into device design is not always a pre…
      Steve Maylish and Dave Hines, Fusion Biotec 05.01.17

    • Testing
      Peruvian Prospects:  The Medical Device Industry of a Country Founded on Precious Metals

      Peruvian Prospects: The Medical Device Industry of a Country Founded on Precious Metals

      It was a lot to take in running on about five hours of sleep following an international flight complete with a lost luggage cliché. Representatives from multiple agencies—governmental, regulatory, medical device companies, hospital purch…
      Dawn A. Lissy, President & Founder, Empirical 04.03.17

    • Materials | R&D & Design
      Collaborating on Custom Materials Development

      Collaborating on Custom Materials Development

      OEMs and contractors can engage with materials suppliers for custom formulations and product development.
      Deepak Prakash, Vancive Medical Technologies 04.03.17


    Breaking News
    • Remote Control Fires Laser at Nano-Gold to Activate Cancer-Killing Immune Cells
    • FDA Clears Varian's Calypso Anchored Beacon Transponder for Lung
    • Clinical Trial Tests 'Tattoo Sensor' as Needleless Glucose Monitor
    • Chip-Based Multiple Myeloma Blood Test Could Eliminate Need for Bone Biopsies
    • Pear Therapeutics and Novartis Ink Deal to Commercialize Prescription Digital Therapeutics
    View Breaking News >
    CURRENT ISSUE

    April 2018

    • India’s New Medical Devices Rules
    • Discovering Packaging’s Hidden Value
    • Deliberate Disposal: Single-Use & Disposables Technologies
    • Illuminating Tubing’s Future
    • View More >

    Copyright © 2018 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.